This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cynosure Introduces Enhanced Elite+ And Apogee+ Workstations For Faster Aesthetic Treatments

WESTFORD, Mass., March 15, 2012 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based treatments for minimally invasive and non-invasive aesthetic applications, today announced it plans to introduce a speed and power enhancement for two of its most popular multi-purpose systems. The Company expects to launch the Elite™+  and Apogee™+ Aesthetic Workstations at the 70th Annual Meeting of the American Academy of Dermatology March 16-20 in San Diego, California.

"With enhanced power, these new workstations can treat 44 percent more area per pulse than our current Elite and Apogee models," said Michael Davin, Cynosure's President and Chief Executive Officer. "The increased speed of treatment translates into higher patient throughput for practitioners and reduced treatment time for patients, while ensuring the safety, comfort and reliability that patients depend on. These next-generation systems demonstrate our focus on delivering innovative technology improvements that enable practitioners to provide the most comprehensive suite of products for applications that are in high demand."

Elite+ is a multi-purpose, dual-wavelength system used to remove unwanted hair, treat facial and leg veins and rejuvenate the skin by removing age spots and sun-damage -- all in a single visit. The revolutionary technology of the Elite+ combines two optimal wavelengths in one system: the 755-nm Alexandrite and the 1064-nm Nd:YAG. Practitioners can switch between wavelengths during a single procedure, allowing them to select the most appropriate laser for any hair or skin type.

Apogee+ is equipped with a 755-nm Alexandrite laser that permanently removes hair on a wide variety of skin types. In addition, it treats benign epidermal pigmented lesions such as age spots, sunspots and freckles. Current U.S. customers will be able to upgrade their existing Elite and Apogee workstations to the plus versions.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.66 -3.20%
FB $116.73 7.20%
GOOG $691.02 -2.10%
TSLA $249.30 -0.86%
YHOO $36.57 -1.00%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs